169 related articles for article (PubMed ID: 28411237)
1. Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy.
Lou M; Liu Q; Ren G; Zeng J; Xiang X; Ding Y; Lin Q; Zhong T; Liu X; Zhu L; Qi H; Shen J; Li H; Shao J
J Biol Chem; 2017 Jun; 292(22):9136-9149. PubMed ID: 28411237
[TBL] [Abstract][Full Text] [Related]
2. Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.
Qi H; Lou M; Chen Y; Liu X; Chen N; Shan J; Ling Z; Shen J; Zhu L; Yen Y; Zheng S; Shao J
Tumour Biol; 2015 Jun; 36(6):4833-42. PubMed ID: 25638032
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.
Wang P; Wu Y; Li X; Ma X; Zhong L
J Biol Chem; 2013 Feb; 288(5):3346-58. PubMed ID: 23223577
[TBL] [Abstract][Full Text] [Related]
4. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
[TBL] [Abstract][Full Text] [Related]
5. Ribonucleotide reductase large subunit M1 plays a different role in the invasion and metastasis of papillary thyroid carcinoma and undifferentiated thyroid carcinoma.
Fang Z; Song R; Gong C; Zhang X; Ren G; Li J; Chen Y; Qiu L; Mei L; Zhang R; Xiang X; Chen X; Shao J
Tumour Biol; 2016 Mar; 37(3):3515-26. PubMed ID: 26453115
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.
Zahedi Avval F; Holmgren A
J Biol Chem; 2009 Mar; 284(13):8233-40. PubMed ID: 19176520
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-glutaredoxin is an efficient electron donor system for mammalian p53R2-R1-dependent ribonucleotide reductase.
Sengupta R; Coppo L; Mishra P; Holmgren A
J Biol Chem; 2019 Aug; 294(34):12708-12716. PubMed ID: 31266802
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
[TBL] [Abstract][Full Text] [Related]
9. Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple Myeloma.
Sagawa M; Ohguchi H; Harada T; Samur MK; Tai YT; Munshi NC; Kizaki M; Hideshima T; Anderson KC
Clin Cancer Res; 2017 Sep; 23(17):5225-5237. PubMed ID: 28442502
[No Abstract] [Full Text] [Related]
10. CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer.
Fang Z; Lin A; Chen J; Zhang X; Liu H; Li H; Hu Y; Zhang X; Zhang J; Qiu L; Mei L; Shao J; Chen X
Oncotarget; 2016 Nov; 7(47):78055-78068. PubMed ID: 27801665
[TBL] [Abstract][Full Text] [Related]
11. Phosphines are ribonucleotide reductase reductants that act via C-terminal cysteines similar to thioredoxins and glutaredoxins.
Domkin V; Chabes A
Sci Rep; 2014 Jul; 4():5539. PubMed ID: 24986213
[TBL] [Abstract][Full Text] [Related]
12. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the ribonucleotide reductase M1-gemcitabine interaction in vivo by N-ethylmaleimide.
Chen Z; Zhou J; Zhang Y; Bepler G
Biochem Biophys Res Commun; 2011 Sep; 413(2):383-8. PubMed ID: 21893046
[TBL] [Abstract][Full Text] [Related]
14. Selenium and the thioredoxin and glutaredoxin systems.
Björnstedt M; Kumar S; Björkhem L; Spyrou G; Holmgren A
Biomed Environ Sci; 1997 Sep; 10(2-3):271-9. PubMed ID: 9315320
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.
Gautam A; Bepler G
Cancer Res; 2006 Jul; 66(13):6497-502. PubMed ID: 16818620
[TBL] [Abstract][Full Text] [Related]
16. E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.
Fang Z; Gong C; Liu H; Zhang X; Mei L; Song M; Qiu L; Luo S; Zhu Z; Zhang R; Gu H; Chen X
Biochem Biophys Res Commun; 2015 Aug; 464(2):407-15. PubMed ID: 26093293
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant function of thioredoxin and glutaredoxin systems.
Holmgren A
Antioxid Redox Signal; 2000; 2(4):811-20. PubMed ID: 11213485
[TBL] [Abstract][Full Text] [Related]
18. Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.
Tóth C; Sükösd F; Valicsek E; Herpel E; Schirmacher P; Renner M; Mader C; Tiszlavicz L; Kriegsmann J
Int J Mol Med; 2017 Nov; 40(5):1457-1465. PubMed ID: 28949378
[TBL] [Abstract][Full Text] [Related]
19. A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development.
Specks J; Lecona E; Lopez-Contreras AJ; Fernandez-Capetillo O
Mol Cell Biol; 2015 Sep; 35(17):2910-7. PubMed ID: 26077802
[TBL] [Abstract][Full Text] [Related]
20. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
